يعرض 1 - 10 نتائج من 93 نتيجة بحث عن '"Risk Factors for Cardiovascular Disease"', وقت الاستعلام: 1.12s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية

    المصدر: Rheumatology Science and Practice; Vol 61, No 5 (2023); 562-568 ; Научно-практическая ревматология; Vol 61, No 5 (2023); 562-568 ; 1995-4492 ; 1995-4484

    وصف الملف: application/pdf

    العلاقة: https://rsp.mediar-press.net/rsp/article/view/3438/2317Test; Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: Prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16(7):380-390. doi:10.1038/s41584-020-0441-1; Kuo C-F, Grainge MJ, Mallen C, Zhang W, Doherty M. Comorbidities in patients with gout prior to and following diagnosis: Case-control study. Ann Rheum Dis. 2016; 75(1): 210-217. doi:10.1136/annrheumdis-2014-206410; Bardin T, Richette P. Impact of comorbidities on gout and hyperuricaemia: An update on prevalence and treatment options. BMC Med. 2017;15(1):123. doi:10.1186/s12916-017-0890-9; Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation. 2007;116(8):894-900. doi:10.1161/CIRCULATIONAHA.107.703389; Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum. 2006;54(8):2688-2696. doi:10.1002/art.22014; De Vera MA, Rahman MM, Bhole V, Kopec JA, Choi HK. Independent impact of gout on the risk of acute myocardial infarction among elderly women: A population-based study. Ann Rheum Dis. 2010;69(6):1162-1164. doi:10.1136/ard.2009.122770; Sanchez-Lozada LG, Rodriguez-Iturbe B, Kelley EE, Nakagawa T, Madero M, Feig DI, et al. Uric acid and hypertension: An update with recommendations. Am J Hypertens. 2020;33(7):583-594. doi:10.1093/ajh/hpaa044; Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol. 2002;282(6):F991-F997. doi:10.1152/ajprenal.00283.2001; Park JJ, Roudier MP, Soman D, Mokadam NA, Simkin PA. Prevalence of birefringent crystals in cardiac and prostatic tissues, an observational study. BMJ Open. 2014;4(7):e005308. doi:10.1136/bmjopen-2014-005308; Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castañeda-Sanabria J, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76(1):29-42. doi:10.1136/annrheumdis-2016-209707; Российское кардиологическое общество. Стабильная ишемическая болезнь сердца. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(11):4076. doi:10.15829/1560-4071-2020-4076; 2021 рекомендации ESC по профилактике сердечно-сосудистых заболеваний в клинической практике. Российский кардиологический журнал. 2022;27(7):5155. doi:10.15829/1560-4071-2022-5155; Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al.; ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-3104. doi:10.1093/eurheartj/ehy339; Drosos GC, Vedder D, Houben E, Boekel L, Atzeni F, Badreh S, et al. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis. 2022;81(6):768-779. doi:10.1136/annrheumdis-2021-221733; Liu SC, Xia L, Zhang J, Lu XH, Hu DK, Zhang HT, et al. Gout and risk of myocardial infarction: A systematic review and metaanalysis of cohort studies. PLoS One. 2015;10(7):e0134088. doi:10.1371/journal.pone.0134088; Huang KH, Tai CJ, Tsai YF, Kuan YH, Lee CY. Correlation between gout and coronary heart disease in Taiwan: A nationwide population-based cohort study. Acta Cardiol Sin. 2019;35(6):634-640. doi:10.6515/ACS.201911_35(6).20190403B; Liang L, Hou X, Bainey KR, Zhang Y, Tymchak W, Qi Z, et al. The association between hyperuricemia and coronary artery calcification development: A systematic review and meta-analysis. Clin Cardiol. 2019;42(11):1079-1086. doi:10.1002/clc.23266; Wijnands JM, Boonen A, Dagnelie PC, van Greevenbroek MM, van der Kallen CJ, Ferreira I, et al. The cross-sectional association between uric acid and atherosclerosis and the role of low-grade inflammation: the CODAM study. Rheumatology (Oxford). 2014;53(11):2053-2062. doi:10.1093/rheumatology/keu239; Essex MN, Hopps M, Bienen EJ, Udall M, Mardekian J, Makinson GT. Evaluation of the relationship between serum uric acid levels and cardiovascular events in patients with gout: A retrospective analysis using electronic medical record data. J Clin Rheumatol. 2017;23(3):160-166. doi:10.1097/RHU.0000000000000496; Wu J, Lei G, Wang X, Tang Y, Cheng H, Jian G, et al. Asymptomatic hyperuricemia and coronary artery disease in elderly patients without comorbidities. Oncotarget. 2017;8(46):80688-80699. doi:10.18632/oncotarget.21079; Busso N, So A. Mechanisms of inflammation in gout. Arthritis Res Ther. 2010;12(2):206. doi:10.1186/ar2952; Schjerning A-M, McGettigan P, Gislason G. Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat Rev Cardiol. 2020;17(9):574-584. doi:10.1038/s41569-020-0366-z; Yang Y, Xian W, Wu D, Huo Z, Hong S, Li Y, et al. The role of obesity, type 2 diabetes, and metabolic factors in gout: A Mendelian randomization study. Front Endocrinol (Lausanne). 2022;13:917056. doi:10.3389/fendo.2022.917056; Барскова ВГ, Ильиных ЕВ, Елисеев МС, Зилов АВ, Насонов ЕЛ. Кардиоваскулярный риск у больных подагрой. Ожирение и метаболизм. 2006;3(8):40-44.; Маркелова ЕИ, Елисеев МС, Попкова ТВ, Ильиных ЕВ, Глухова СИ, Барскова ВГ. Распространенность и факторы риска развития артериальной гипертонии у пациентов с подагрой. Научно-практическая ревматология. 2020;58(6): 701-707. doi:10.47360/1995-4484-2020-701-707; Roughley MJ, Belcher J, Mallen CD, Roddy E. Gout and risk of chronic kidney disease and nephrolithiasis: Meta-analysis of observational studies. Arthritis Res Ther. 2015;17(1):90. doi:10.1186/s13075-015-0610-9; Yu KH, Kuo CF, Luo SF, See LC, Chou IJ, Chang HC, et al. Risk of end-stage renal disease associated with gout: A nationwide population study. Arthritis Res Ther. 2012;14(2):R83. doi:10.1186/ar3806; https://rsp.mediar-press.net/rsp/article/view/3438Test

  6. 6
    دورية أكاديمية
  7. 7
    كتاب
  8. 8
    كتاب
  9. 9
    كتاب
  10. 10
    كتاب